David Hirsch
CIK 1619884 · last filed 2024-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.19M
Companies
6
Total Filings
34
Lifetime Open-Market Net
$7.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPID | Director | 3,422,252 | $2.06 | $7.05M | $0 | 5 | 2024-05-28 |
| Tricida, Inc. (TCDA) Delisted | Director | 3,047,318 | $0.11 | $329.1K | $2.50M | 5 | 2022-06-16 |
| Molecular Templates, Inc. (MTEM) Delisted | Director | 213,379 | $0.00 | $21 | $17.00M | 10 | 2022-06-06 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 2,714,245 | $9.50 | $25.79M | $4.00M | 4 | 2021-07-26 |
| COLL | Director | 82,504 | $35.90 | $2.96M | $1.92M | 4 | 2020-05-22 |
| ESPR | Director | 57,325 | $3.18 | $182.3K | -$17.60M | 6 | 2019-09-03 |
Recent Filings · Page 3 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-09-03 | ESPR | Mixed | −2,253 | -$72.3K | EDGAR |
| 2019-06-04 | Tricida, Inc. (TCDA) Delisted | Grant (A) | +1,879 | $0 | EDGAR |
| 2019-05-30 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-29 | ESPR | Grant (A) | +4,707 | $0 | EDGAR |
| 2018-09-25 | Molecular Templates, Inc. (MTEM) Delisted | Buy (P) | +365,000 | $2.01M | EDGAR |
| 2018-07-02 | Tricida, Inc. (TCDA) Delisted | Mixed | +3,023,366 | $2.50M | EDGAR |
| 2018-06-04 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-29 | ESPR | Grant (A) | +2,253 | $0 | EDGAR |
| 2017-12-12 | ESPR | Sell (S) | −1,000,000 | -$17.34M | EDGAR |
| 2017-10-11 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.